Jaco Pretorius (48), a handyman, churchgoer and family man from Freeway Park, is urgently in need of the community’s assistance. Diagnosed with an aggressive form of skin cancer ...

It's incredibly scary to experience a random symptom out of nowhere, especially when it won't go away. So when I saw Reddit ...

On Tuesday, 2662 stocks advanced, 1339 declined and 143 remained unchanged on Bombay Stock Exchange with advance decline ...

Risk factors for cutaneous squamous cell carcinoma recurrence, metastasis, and disease-specific death: a systematic review and meta-analysis. JAMA Dermatol . 2016;152(4):419-428. doi:10.1001 ...

Traws Pharma published promising data on rigosertib for treating RDEB-associated SCC, showing an 80% response rate in clinical trials. The company is actively seeking development and ...

In a phase 3, randomized trial, we enrolled patients with local or regional cutaneous squamous-cell carcinoma, after surgical resection and postoperative radiotherapy, at high risk for recurrence ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...

Operation Tidal Wave is truly a first of its kind operation, utilizing 287(g) resources, integrating with the state and local law enforcement to assist in the day-to-day ICE mission." ...

In patients with up to 63% central squamous carcinoma, ivonescimab demonstrated a safety profile comparable to the control group. This highlights its potential to overcome the limitations of ...

A patient recounts his squamous cell carcinoma diagnosis, treatment and recovery, emphasizing self-advocacy in navigating the medical system. It was a Friday afternoon, and I was sitting in ...

The sBLA is supported by data from the phase 3 KEYNOTE-689 which evaluated pembrolizumab in an estimated 704 treatment-naïve patients.